Nusano
  • Company
    • Leadership
    • Mission & Values
    • West Valley City
    • Contact Us
  • Technology
  • Life Sciences
    • Medical Isotopes
    • Request Quote
    • R&D Collaboration
    • Advisory Board
    • About Nuclear Med
  • Energy
    • HALEU
    • Nuclear Fuel Cycle
  • Industrial
  • Batteries
  • News
    • Press Releases
    • Video
    • Podcast
  • Careers
    • Current Openings
    • Life in Utah
Select Page
Global radioisotope shortage hits patients in Pennsylvania

Global radioisotope shortage hits patients in Pennsylvania

by Scott Larrivee | Nov 11, 2022 | Industry News

Nov. 11, 2022 – Pennsylvania-based WellSpan Health is notifying patients that global medical radioisotope shortages will require patients to delay, reschedule, or pursue other imaging solutions. On its website, the health system writes: A critical world-wide shortage...
Toronto Star: Sudden shortage of vital isotope hitting Canadian hospitals

Toronto Star: Sudden shortage of vital isotope hitting Canadian hospitals

by Scott Larrivee | Nov 10, 2022 | Industry News

Nov. 10, 2022 – The unexpected shut down of a nuclear reactor in Belgium is creating issues for patients in Canada needing medical imaging procedures. The Toronto Star reports: QEII  [Queen Elizabeth II] hospital performs some 6,000 of those diagnostic imaging tests...
University of Missouri responds to global radioisotope shortage

University of Missouri responds to global radioisotope shortage

by Scott Larrivee | Feb 12, 2022 | Industry News

Feb. 12, 2022 – The failure of a nuclear reactor to come back online in the Netherlands is posing medical radioisotope shortages worldwide. In response, the University of Missouri Research Reactor (MURR) is attempting to help alleviate supply chain challenges. Imaging...
Reuters: EU may face shortage of key materials for diagnostics, cancer treatments

Reuters: EU may face shortage of key materials for diagnostics, cancer treatments

by Scott Larrivee | Dec 7, 2021 | Industry News

European officials are warning that increasing demand and aging infrastructure may limit the availability of radioisotopes needed for medical imaging and advanced therapeutic treatments. Reuters reports: The EU is the world’s biggest producer of Molybdenum-99, a...
Next Entries »

Recent Posts

  • Talk Radioisotopes: Paul Schrimpf, Proprietor & Entrepreneur, Cyrall
  • Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
  • Nusano CEO Chris Lowe on Connor Group Podcast
  • dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply
  • Ratio Therapeutics and Nusano Enter Long-Term, Multi-Isotope Supply Agreement to Boost Production of Cancer Radiopharmaceuticals

Recent Comments

No comments to show.
Nusano
Supplying the fight against cancer & enabling life-changing innovations
  • Follow
  • Follow
  • Follow
Company
about us
Leadership
Contact us
technology

The Nusano Platform
R&D Collaboration

Resources
News
Careers
Suppliers
© 2025 Nusano | Web design
Privacy Policy – Terms of Service